Moshe Mittelman, MD¹, Uwe Platzbecker, MD², Boris V Afanasyev, Professor^3*, Sebastian Grosicki, MD, PhD⁴, Raymond SM Wong, MD⁵, Achilles Anagnostopoulos, MD⁶, Benjamin Brenner, MD⁷, Claudio Denzlinger, MD^8*, Giuseppe Rossi, MD⁹, Arnon Nagler, MD, MSc¹⁰, Ana Isabel Rosell Mas, PhD^11*, Frank Mannino, PhD^12*, Nicole L. Stone, PhD¹², Geoffrey Chan, MD¹², Yasser Mostafa Kamel, MD, MSc, MBA¹² and Dominik L.D. Selleslag, MD¹³

¹Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
²Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany
³Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation, First Pavlov State Medical University of Saint-Petersburg, Saint-Petersburg, Russia
⁴Department of Hematology, Silesian Medical University, Katowice, Poland
⁵Prince of Wales Hospital, Shatin, Hong Kong
⁶Hematology Department and HCT Unit, G. Papanikolaou General Hospital, Athens, Greece
⁷Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel
⁸Marienhospital Stuttgart, Stuttgart, Germany
⁹UO Ematologia, Azienda Ospedaliera Spedali Civili, Brescia, Italy
¹⁰Division of Hematology, Sheba Medical Center, Ramat Gan, Israel
¹¹Hospital Virgen de la Victoria, Málaga, Spain
¹²Novartis Pharmaceuticals Corporation, East Hanover, NJ
¹³Department of Hematology, AZ St-Jan Brugge AV, Brugge, Belgium

Emilia J Kozyra, MSc^1*, Shinsuke Hirabayashi, MD^1*, Victor Bengt Pastor Loyola, MSc^1*, Bartlomiej Przychodzen, MSc^2*, Axel Karow, MD^3*, Albert Catala, MD^4*, Barbara De Moerloose, MD, PhD^5*, Michael Dworzak, MD^6*, Henrik Hasle, MD⁷, Riccardo Masetti, MD^8*, Markus Schmugge, MD⁹, Owen Smith¹⁰, Jan Starý, MD^11*, Marek Ussowicz, MD^12*, Marry M. van den Heuvel-Eibrink, MD, PhD^13*, Vit Campr, MD^14*, Rita Devito, MD^15*, Pascale Paepe, MD, PhD^16*, Miguel Hernandez-Marti, MD^17*, Gitte Kerndrup, MD^18*, Roos Leguit, MD^19*, Jadwiga Maldyk, MD^20*, Maureen OxSullivan, MD^21*, Ingrid Simonitsch-Klupp, MD^22*, Irith Baumann, MD^23*, Franco Locatelli, Prof, MD, PhD^24*, Jaroslaw P. Maciejewski, MD, Ph.D.², Brigitte Strahm, MD^1*, Charlotte M Niemeyer, Prof, MD¹ and Marcin W Wlodarski, MD^1*

¹University Children´s Hospital Freiburg, Division of Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany
²Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
³Department of Pediatrics, University Hospital Ber, Bern, Switzerland
⁴Dep of Hematology, Hospital Sant Joan de Déu, Barcelona, Spain
⁵Department of Pediatrics, Ghent University, Ghent, Belgium
⁶Department of Pediatrics, Medical University of Vienna, St. Anna Children's Hospital and Children’s Cancer Research Institute, Vienna, Austria
⁷Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
⁸Pediatric Oncology and Hematology, University of Bologna, Bologna, Italy
⁹Haematology, University Children's Hospital Zurich, Zurich, Switzerland
¹⁰Department of Haematology, Our Lady's Children's Hospital, Dublin, Ireland
¹¹Department of Pediatric Hematology and Oncology, Charles University and Univ Hospital Motol, Prague, Czech Republic
¹²Dep of Pediatric Hematology/ Oncology, Charles University and Univ Hospital Motol, Prague, Czech Republic
¹³Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
¹⁴Institute of Pathology, University Hospital Motol, Prague, Czech Republic
¹⁵Dep of Pathology, Bambino Gesu' Children's Hospital, Rome, Italy
¹⁶Department of Pathology, University of Ghent, Ghent, Belgium
¹⁷Hospital Iniversitario La Fe, Valencia, Spain
¹⁸Institute of Pathology, Aarhus University Hospital Skejby, Aarhus, Denmark
¹⁹Pathology, University Medical Center Utrecht, Utrecht, Netherlands
²⁰Department of Pediatric Pathomorphology, Medical UniversityWarszawa, Warszawa, Poland
²¹Histology Laboratory, Our Lady´s Children´s Hospital Crumlin, Dublin, Ireland
²²Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria
²³Dep of Pathology, Clinical Center Böblingen, Böblingen, Germany
²⁴Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy

Koichi Takahashi, MD¹, Feng Wang, Ph.D.^2*, Seth Sahil^2*, Jianhua Zhang^2*, Curtis Gumbs^2*, Ghayas C. Issa, MD^3*, Christopher B. Benton, MD¹, Sherry Pierce, BSN, BA^1*, Elias Jabbour¹, Naval Daver, MD¹, Tapan Kadia, MD¹, Courtney DiNardo, MD¹, Hagop M. Kantarjian, MD¹, Andrew Futreal, PhD^2* and Guillermo Garcia-Manero, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Rami S. Komrokji, MD¹, Mintallah Haider, MD¹, Najla H. Al Ali, BDS, MSc^1*, Jeffrey E Lancet, M.D.², Qing Zhang, MD^3*, Pearlie K Epling-Burnette, PhD⁴, Alan F. List, MD¹ and Eric Padron, MD¹

¹Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²Dept. of Malignant Hematology. H. Lee Moffitt Cancer Center, Tampa, FL
³H. Lee Moffitt Cancer Center, Tampa, FL
⁴Immunology Program, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Sophie Park, MD, PhD¹, Jean-François Hamel^2*, Andrea Toma^3*, Charikleia Kelaidi, MD^4*, Maria Campelo Diez^5*, Valeria Santini, MD⁶, Enrico Balleari, MD^7*, Jennifer Schemenau^8*, Rosa Sapena^9*, Katharina Goetze, MD^10*, Catharina Mueller-Thomas, MD^11*, Odile Beyne-Rauzy, MD, PhD^12*, Aspasia Stamatoullas, MD^13*, Ioannis Kotsianidis¹⁴, Agnes Guerci, MD^15*, Dominique Bordessoule¹⁶, Pascale Cony-Makhoul, M.D.^17*, Stéphane Cheze, MD, PhD^18*, Eric Wattel, MD PhD¹⁹, Christian Rose²⁰, Norbert Vey²¹, Ulrich Germing, MD^22*, Guillermo Sanz, MD, PhD²³, François Dreyfus, MD^24* and Pierre Fenaux, MD, PhD²⁵

¹CHU de Grenoble, Clinique Universitaire d’Hématologie, Université Joseph Fourier, Grenoble Cedex 9, France
²PRES LUNAM, CHU Angers service des Maladies du Sang et INSERM U 892, Angers, France
³CHU Henri Mondor, Creteil, France
⁴Hopital Avicenne -Paris 13 University, Bobigny, France
⁵Salamanca, Salamanca Hospital universitario, Spain, France
⁶AOU Careggi, University of Florence, Florence, Italy
⁷Genova Hospital, Genova, Italy
⁸Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany
⁹Clinical Hematology, CHU Cochin, Paris, France
¹⁰Technische Universität München, München, Germany
¹¹Technische Universitaet Muenchen, Muenchen, Germany
¹²Service de medecine Interne, CHU Purpan, Toulouse, France
¹³Clinical Hematology, CENTRE HENRI BECQUEREL, Rouen, France
¹⁴Department of Hematology, Democritus University of Thrace, Alexandroupolis, Greece
¹⁵CHU de Nancy, Nancy, France
¹⁶Hematologie Clinique, CHU de Limoges, Limoges, France
¹⁷Hematology department, Centre Hospitalier Annecy-Genevois, Site Annecy, Metz-Tessy, France
¹⁸Institut d’Hématologie de Basse-Normandie, CHU Caen Hôpital Côte de Nacre, Caen, France
¹⁹Lyon I University, Lyon, France
²⁰Service d'Onco Hematologie, Université Catholique de Lille, Groupe Francophone des Myelodysplasies (GFM), Lille, France
²¹Hematology, Institut Paoli-Calmettes, Marseille, France
²²Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
²³Hospital Universitario La Fe, Spanish MDS Cooperative Group, Valencia, Spain
²⁴Cochin hospital, University Paris 5, Paris, France
²⁵Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France

Amer M. Zeidan, MBBS, MHS¹, Joshua F. Zeidner, MD², Amy Duffield, MD^3*, Hanna A. Knaus, MD^3,4*, Anna Ferguson, BSN, RN^3*, Katherine Sheldon^3*, Amy E. DeZern, MD, MHS⁵, Ivana Gojo, MD⁴, Steven D. Gore, MD⁶, Howard Streicher, MD^7*, Leo Luznik^3* and B. Douglas Smith³

¹Yale University School of Medicine, New Haven, CT
²Department of Medicine, University of North Carolina, Chapel Hill, NC
³Johns Hopkins University, Baltimore, MD
⁴Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
⁵Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
⁶Yale Cancer Center, New Haven, CT
⁷NCI NIH-CTEP, Rockville, MD

Maya Thangavelu, PhD¹, Wanlong Ma, BS^1*, Steven Brodie, Ph.D^2*, Christopher Mixon, MD^3*, Wayne Chen, MD^1*, Sally Agersborg, MD, PhD^1* and Maher Albitar¹

¹NeoGenomics Laboratories, Irvine, CA
²NeoGenomics Laboratories, Ft. Myers, FL
³NeoGenomics Laboratories, Nashville, TN

Brooke Snetsinger, MSc^1*, Emily Heath, BSc^2* and Michael J. Rauh, MD, PhD³

¹Dept. Pathology & Molecular Medicine, Queen's University, Kingston, ON, Canada
²Dept. Pathology & Molecular Medicine, Queen's University, Kingston, Canada
³Department of Pathology & Molecular Medicine, Queen's University, Kingston, ON, Canada

David Valcarcel, MD, PhD¹, Amit Verma, MD², Uwe Platzbecker, MD³, Valeria Santini, MD⁴, Aristoteles Giagounidis, MD⁵, María Díez-Campelo, MD, PhD^6*, Jan Janssen, MD^7*, Richard F. Schlenk, MD⁸, Gianluca Gaidano, MD, PhD⁹, Jaime Perez de Oteyza, MD^10*, Ann L Cleverly, MD^11*, Alan Y Chiang, PhD^12*, Michael Lahn, MD^12*, Durisala Desiaih, PhD^12*, Susan C. Guba, MD¹³, Alan F. List, MD¹⁴ and Rami S. Komrokji, MD¹⁵

¹Hospital Universitario Vall d'Hebron, Spanish MDS Cooperative Group, Barcelona, Spain
²Department of Medicine-Oncology, Albert Einstein College of Medicine, Bronx, NY
³Carl Gustav Carus an der Technischen Universität, Universitätsklinikum, Dresden, Germany
⁴AOU Careggi, University of Florence, Florence, Italy
⁵Klinik für Onkologie, Hämatologie und Palliativmedizin, Marienhospital Düsseldorf, Düsseldorf, Germany
⁶Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
⁷Onkologische Gemeinschaftspraxis Dres, Westerstede, Germany
⁸University Hospital of Ulm, Ulm, Germany
⁹Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
¹⁰Department of Hematology, Hospital Ramon y Cajal, Madrid, Spain
¹¹Erl Wood, Eli Lilly and Company, Erl Wood, United Kingdom
¹²Eli Lilly and Company, Indianapolis, IN
¹³Eli Lilly and Company, Indianapolis
¹⁴Department of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁵Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Maya Thangavelu, PhD¹, Wanlong Ma, BS^1*, Steven Brodie, Ph.D^2*, Christopher Mixon, MD^3*, Wayne Chen, MD^1*, Sally Agersborg, MD, PhD^1* and Maher Albitar, MD¹

¹NeoGenomics Laboratories, Irvine, CA
²NeoGenomics Laboratories, Ft. Myers, FL
³NeoGenomics Laboratories, Nashville, TN

Wolfgang Kern, MD, Manja Meggendorfer, PhD^*, Claudia Haferlach, MD, Susanne Schnittger, PhD and Torsten Haferlach

MLL Munich Leukemia Laboratory, Munich, Germany

Meritxell Nomdedeu^1,2*, Xavier Calvo^3*, Dolors Costa^1*, Montserrat Arnan, MD, PhD^4*, Helena Pomares, MD^5*, Guillermo Sanz, MD, PhD⁶, David Valcarcel, MD, PhD⁷, Elisa Luño^8*, Fernando Ramos^9*, Maria Diaz-Campelo^10*, Rosa Collado^11*, Raquel de Paz^12*, Jose-Francisco Falantes^13*, Carme Pedro^3*, Jordi Esteve¹⁴, Rafael Andreu^15*, Maria-Teresa Ardanaz^16*, Joaquin Sanchez-Garcia^17*, Mar Tormo, MD, PhD¹⁸, Maria-Teresa Cedena^19*, Beatriz Arrizabalaga, MD^20*, Bernardo Gonzalez^21*, Victor Marco^22*, Salut Brunet, MD, PhD^23* and Arturo Pereira^1*

¹Hospital Clinic, Spanish MDS Cooperative Group, Barcelona, Spain
²Fundació Clínic per la Recerca Biomèdica, Spanish MDS Cooperative Group, Barcelona, Spain
³Hospital del Mar, Spanish MDS Cooperative Group, Barcelona, Spain
⁴Hospital Durán i Reynals, Spanish MDS Cooperative Group, Hospitalet de Llobregat, Spain
⁵Hospital Duran i Reynals, Spanish MDS Cooperative Group, Hospitalet de Llobregat, Spain
⁶Hospital Universitario La Fe, Spanish MDS Cooperative Group, Valencia, Spain
⁷Hospital Universitario Vall d'Hebron, Spanish MDS Cooperative Group, Barcelona, Spain
⁸Hospital Universitario Central Asturias, Oviedo, Spain
⁹Hospital Universitario de Leon, Spanish MDS Cooperative Group, Leon, Spain
¹⁰Hospital Universitario de Salamanca, Spanish MDS Cooperative Group, Salamanca, Spain
¹¹Hospital General Universitario de Valencia, Spanish MDS Cooperative Group, Valencia, Spain
¹²Hospital Universitario La Paz, Spanish MDS Cooperative Group, Madrid, Spain
¹³Hospital Universitario Virgen del Rocío, Spanish MDS Cooperative Group, Sevilla, Spain
¹⁴Hospital Clinic de Barcelona, Spanish MDS Cooperative Group, Barcelona, Spain
¹⁵Hospital Doctor Peset, Spanish MDS Cooperative Group, Valencia, Spain
¹⁶Hospital de Txagorritxu, Spanish MDS Cooperative Group, Vitoria-Gasteiz, Spain
¹⁷Hospital Universitario Reina Sofia, Spanish MDS Cooperative Group, Cordoba, Spain
¹⁸Hospital Clínico Universitario de Valencia, Valencia, Spain
¹⁹Hospital Universitario 12 de Octubre, Spanish MDS Cooperative Group, Madrid, Spain
²⁰Hospital Universitario Cruces, Spanish MDS Cooperative Group, Bilbao, Spain
²¹Hospital Universitario de Canarias, Spanish MDS Cooperative Group, Santa Cruz de Tenerife, Spain
²²Hospital Arnau de Vilanova, Spanish MDS Cooperative Group, Lleida, Spain
²³Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

David Sallman, M.D.¹, Eric Padron, M.D.², Christine Vaupel, PhD^3*, Thomas Cluzeau, MD, PhD^4,5,6,7*, Najla H. Al Ali, BDS, MSc^8*, Jeffrey E Lancet, MD⁸, Jeff Hall, PhD^3*, Alan F. List, MD⁹ and Rami S. Komrokji, MD⁸

¹Dept. of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
²Division of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL
³Genoptix, Inc., a Novartis company, Carlsbad, CA
⁴INSERM U1065, Centre Mediterraneen de Medecine Moleculaire, Nice, France
⁵Hematology, Saint Louis Hospital, Paris, France
⁶H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁷French Group of Myelodysplasia, Paris, France
⁸Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁹Department of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL

Claudia Haferlach, MD, Manja Meggendorfer, PhD^*, Wolfgang Kern, MD, Susanne Schnittger, PhD and Torsten Haferlach

MLL Munich Leukemia Laboratory, Munich, Germany

Federica Loscocco, PhD^1*, Giuseppe Visani, M.D.^1*, Elisa Giacomini^2*, Annamaria Ruzzo^2*, Sara Galimberti, MD^3*, Maria Teresa Voso, MD, PhD^4*, Carlo Finelli, MD^5*, Elena Ciabatti^6*, Emiliano Fabiani^4*, Francesco Graziano^7*, Sara Barulli^1*, Antonio Volpe, MD^8*, Domenico Magro^9*, Pier Paolo Piccaluga, MD, PhD¹⁰, Fabio Fuligni^11*, Marco Vignetti^12*, Paola Fazi^12*, Alfonso Piciocchi^12*, Cristina Clissa, M.D.^1*, Elisa Gabucci^1*, Marco Rocchi^13*, Mauro Magnani^2* and Alessandro Isidori, M.D. PhD¹

¹Hematology and Stem Cell Transplant Center, AORMN Hospital, Pesaro, Italy
²Department of Biomolecular Sciences, Section of Biochemistry and Molecular Biology, University of Urbino "Carlo Bo", Urbino, Italy
³UO University Hematology, AOU Pisana, Pisa, Italy
⁴Hematology, Catholic University, Rome, Italy
⁵Hematology, S.Orsola-Malpighi University Hospital, Bologna, Italy
⁶University of Pisa, Department of Clinical and Experimental Medicine, Section of Hematology, Italy, Pisa, Italy
⁷Oncology, Marche Nord Hospital, Pesaro, Italy
⁸Hematology, S.Giuseppe Moscati Hospital, Avellino, Italy
⁹Hematology, Pugliese-Ciacco Hospi, Catanzaro, Italy
¹⁰Department of Experimental, Diagnostic, and Specialty Medicine, Bologna University, Bologna, Italy
¹¹The Hospital for Sick Children, Paediatric Laboratory Medicine (PLM), Toronto, ON, Canada
¹²GIMEMA Data Center, Rome, Italy
¹³Institute of Biomathematics, Urbino University, Urbino, Italy

Amer M. Zeidan, MBBS, MHS¹, Jessica B. Long, PhD^2*, Rong Wang, PhD^2*, James B. Yu, MD^1*, Jane Hall^2*, Gregory Abel, MD, MPH³, Steven D. Gore, MD¹, Cary P. Gross, MD^1*, Xiaomei Ma, PhD^2* and Amy J. Davidoff, PhD^2*

¹Yale University School of Medicine, New Haven, CT
²Yale University School of Public Health, New Haven, CT
³Dana-Farber Cancer Inst., Boston, MA

Louise De Swart, MD^1*, Tom Johnston, PhD^2*, Alexandra Smith^3*, Pierre Fenaux, MD, PhD⁴, Argiris Symeonidis, MD, PhD⁵, Jaroslav Cermak, MD, Ph.D.⁶, Eva Hellström-Lindberg, MD, PhD^7*, Guillermo Sanz, MD, PhD⁸, Reinhard Stauder, MD, MSc^9*, Luca Malcovati, MD^10*, Ulrich Germing, MD^11*, Gerwin Huls, MD, PhD^12*, Mette Skov Holm^13*, Moshe Mittelman, MD¹⁴, Krzysztof Madry^15*, Aurelia Tatic, MD^16*, Antonio Medina Almeida^17*, Aleksandar Savic¹⁸, Sophie Park, MD, PhD¹⁹, Odile Beyne-Rauzy, MD, PhD^20*, Raphaël Itzykson, MD, PhD²¹, Corine van Marrewijk^1*, David Bowen, MD, PhD²² and Theo de Witte, MD, PhD²³

¹Hematology, Radboudumc, Nijmegen, Netherlands
²University of York, York, United Kingdom
³Epidemiology and Cancer Statistics Group, University of York, York, United Kingdom
⁴University Paris 7 Diderot, Hôpital Saint-Louis, Paris, France
⁵Hematology, University of Patras Medical School, Patras, Greece
⁶Department of Clinical Hematology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
⁷Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
⁸Servicio de Hematologia, Hospital Universitario La Fe, Valencia, Spain
⁹Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria
¹⁰Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Pavia, Italy
¹¹Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
¹²Department of Hematology, Radboud university medical center, Nijmegen, Netherlands
¹³Dept of Hematology, Aarhus University Hospital, Aarhus, Denmark
¹⁴Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
¹⁵Hematology Oncology and Internal Medicine, Warszawa Medical University, Warszawa, Poland
¹⁶Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
¹⁷Instituto Português de Oncologia de Lisboa,, Serviço de Hematologia,, Lisbon, Portugal
¹⁸Clinic of Hematology, Clinical Center of Vojvodina, Novi Sad, Serbia
¹⁹Cochin Hospital, University Paris 5, Paris, France
²⁰Service de medecine Interne, CHU Purpan, Toulouse, France
²¹Hematology Department, Saint-Louis Hospital, University Paris 7, Paris, France
²²St. James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom
²³Nijmegen Center for Molecular Life Sciences, Dep. of Tumor Immunology, Radboud University of Nijmegen Medical Centre, Nijmegen, Netherlands

Ilaria Ambaglio, MD^1,2*, Valeria Pinto, MD^3*, Domenico Girelli, MD, PhD⁴, Chiara Elena, MD^1,2*, Natascia Campostrini^4*, Daniela Pietra, PhD^2,5*, Anna Gallì^1,2*, Erica Travaglino^1,2*, Mario Cazzola, MD^2,5, Gian Luca Forni, MD^3* and Luca Malcovati, MD^1,2*

¹Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Pavia, Italy
²Department of Molecular Medicine, University of Pavia, Pavia, Italy
³Ematologia - Centro della Microcitemia ed Anemie Congenite, Ospedale Galliera, Genova, Italy
⁴Department of Medicine, Section of Internal Medicine, University of Verona, Policlinico G.B. Rossi, Verona, Italy
⁵Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Kevin E Fisher, MD, PhD^1*, Hadi Sayeed, MS^1*, Dolores Lopez-Terrada, MD, PhD^1*, Alison A Bertuch, MD, PhD² and Maria Monica Gramatges, MD, PhD²

¹Pathology and Immunology, Baylor College of Medicine, Houston, TX
²Pediatrics, Hematology/Oncology, Baylor College of Medicine, Houston, TX

Aristoteles Giagounidis, MD, PhD¹, Alan F. List, MD², Eva Hellström-Lindberg, MD, PhD^3*, Ghulam J. Mufti, MD, PhD⁴, Brigitte Schlegelberger, MD, PhD⁵, John Morrill^6*, Chengqing Wu, PhD^6*, Barry S. Skikne, MD⁶, Pierre Fenaux, MD, PhD⁷ and Gudrun Göhring, MD^5*

¹Marien Hospital Düsseldorf, Düsseldorf, Germany
²Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
³Karolinska University Hospital, Stockholm, Sweden
⁴King's College Hospital, London, United Kingdom
⁵Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany
⁶Celgene Corporation, Summit, NJ
⁷Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France

Koichi Takahashi, MD¹, Hagop M. Kantarjian, MD¹, Keyur Patel, MD^2*, Carlos E Bueso-Ramos^2*, Tapan Kadia, MD¹, Elias Jabbour¹, Courtney DiNardo, MD¹, Naval Daver, MD¹, Sherry Pierce, BSN, BA^1*, Andrew Futreal, PhD^3* and Guillermo Garcia-Manero, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Marta Cabezón^1*, Yulia Medvedeva, PhD^2*, Joan Bargay, MD, PhD^3*, Blanca Xicoy, MD, PhD^1*, Sílvia Marcé, PhD^1*, Ramon Guàrdia, MD, PhD^4*, Salut Brunet, MD, PhD^5*, Carmen Pedro, MD, PhD^6*, Mar Tormo, MD, PhD⁷, Victor Marco^8*, Lourdes Escoda, MD, PhD^9*, Llorenç Font, MD, PhD^10*, Elena Rámila, MD, PhD^11*, David Valcárcel, MD, PhD¹², Josep Maria Martí, MD, PhD^13*, Josep Borras^3*, Evarist Feliu, MD, PhD^1*, Fuensanta Millá, MD, PhD^1*, Tanya Vavouri, PhD^14* and Lurdes Zamora, PhD^1*

¹Hematology Service, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras, Universitat Autònoma de Barcelona, Badalona, Spain
²Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain
³Hospital Son Llàtzer, Palma de Mallorca, Spain
⁴ICO- Hospital Josep Trueta, Girona, Spain
⁵Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
⁶Hospital del Mar, Barcelona, Spain
⁷Hospital Clínico Universitario de Valencia, Valencia, Spain
⁸Hospital Arnau de Vilanova, Spanish MDS Cooperative Group, Lleida, Spain
⁹ICO-Hospital Joan XXIII, Tarragona, Spain
¹⁰Hospital Verge de la Cinta, Tortosa, Spain
¹¹Hospital Parc Taulí, Sabadell, Spain
¹²Hospital Vall d'Hebrón, Barcelona, Spain
¹³Hospital Mútua de Terrassa, Terrassa, Spain
¹⁴Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Josep Carreras Leukemia Research Institute (IJC)., Badalona, Spain

Michael R. Savona, MD¹, Olatoyosi Odenike, MD², Philip C. Amrein, MD³, David P. Steensma, MD⁴, Wael A. Harb, MD⁵, Amy E. DeZern, MD, MHS⁶, Laura C. Michaelis, MD⁷, Stefan Faderl, MD^8*, James N. Lowder, MD^9*, Pietro Taverna, PhD^9*, Aram Oganesian, PhD^9*, Richa Dua, PharmD^9*, Roya Nawabi^9*, Mohammad Azab, MD⁹ and Guillermo Garcia-Manero, MD¹⁰

¹Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
²University of Chicago, Chicago, IL
³Massachusetts General Hospital, Boston, MA
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Horizon Oncology Center, Lafayette, IN
⁶Johns Hopkins University Hospital, Baltimore, MD
⁷Medical College of Wisconsin, Milwaukee, WI
⁸Hackensack University Medical Center, Hackensack, NJ
⁹Astex Pharmaceuticals, Inc., Pleasanton, CA
¹⁰The University of Texas M.D. Anderson Cancer Center, Houston, TX

Anna Schuck, MD^1*, Marie Götte^1*, Judith Neukirchen, MD^1*, Andrea Kuendgen, MD^2*, Norbert Gattermann, MD³, Guido Kobbe, MD^1*, Ulrich Germing, MD^2* and Rainer Haas, MD^2*

¹Dept. of Hematology, Oncology and clinical Immunology, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany
²Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
³Dept. of Hematology, Oncology, and clinical Immunology, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany

Shannon Somer Stockton, BA^1*, Vasu Malhotra^2*, Xiaomin Lu, Ph.D.^3*, Maya Thangavelu, PhD⁴, Maher Albitar⁴ and Christopher R. Cogle, M.D.¹

¹Division of Hematology/Oncology, Department of Medicine, University of Florida, Gainesville, FL
²University of Florida, Gainesville, FL
³Department of Biostatistics, University of Florida, Gainesville, FL
⁴NeoGenomics Laboratories, Irvine, CA

Meagan A. Jacoby, MD, PhD¹, Camille N. Abboud, MD, FACP², John F Dipersio, MD, PhD³, Amanda F. Cashen, MD⁴, Matthew J. Walter, MD⁴, Rigoberto De Jesus Pizarro^5* and Geoffrey L. Uy, MD⁶

¹Department of Medicine, Division of Oncology, Washington University in St. Louis, Saint Louis, MO
²BMT and Leukemia Program, Washington University School of Medicine, Saint Louis, MO
³Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
⁴Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁵University of Puerto Rico Medical School, San Juan, PR
⁶Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Hawk Kim, MD, PhD¹, Je-Hwan Lee, MD, PhD², Won-Sik Lee, MD³, Inho Kim⁴, Joon Ho Moon, M.D., Ph.D.⁵, Chul Won Choi, MD, PhD^6*, Ho Sup Lee, MD, PhD^7*, Jinny Park⁸, Ho-Jin Shin⁹, Kyoung Ha Kim, MD^10*, Su-Hee Cho, MD, PhD^11*, Sung-Yong Kim, MD^12* and Yoo-Jin Kim¹³

¹Ulsan University Hospital, Department of Hematology and Oncology, Associate Professor, Ulsan, South Korea
²Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
³Dept. of Internal Med./Hem., Inje Univ. Busan Baik-Hospital, Busan, South Korea
⁴Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea
⁵Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, South Korea
⁶Hemato-oncology, Korea university medical center, Guro hospital, Seoul, South Korea
⁷Department of Hematology/Oncology, Kosin University Gosper Hospital, Busan, South Korea
⁸Gachon University Gil Hospital, Gachon University of Medicine and Science, Incheon, South Korea
⁹Pusan National University Hospital, Busan, South Korea
¹⁰Hematology/Oncology, Soonchunhyang University Hospital, Seoul, South Korea
¹¹Division of Hemato-oncology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, South Korea
¹²Hematology/Oncology, Konkuk University Medical Center, Seoul, South Korea
¹³Department of Internal Medicine, St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea

Manabu Hirai, MD, PhD^*, Atsushi Inoue, MD^*, Mitsuharu Hashimura, MD^*, Mizuki Aimoto, MD, PhD^* and Erina Sakamoto, MD, PhD^*

Hematology, Shitennoji Hospital, Osaka, Japan

Chunkang Chang, MD, PhD^1*, Youshan Zhao, MD^1*, Feng Xu^2* and Xiao Li, MD, PhD¹

¹Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
²Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China

Manabu Fujisawa, MD^1*, Yasuhito Suehara, MD^1*, Kota Fukumoto, MD^1*, Yoshiaki Usui, MD^1*, Kentaro Narita, MD^2*, Masami Takeuchi, MD^1* and Kosei Matsue, MD/PhD³

¹Department of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan
²Hematology/Oncology Department, Kameda Medical Center, Kamogawa city, Japan
³Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan

Maliha Khan, MD^1*, Bodden Kristy^1*, Tapan Kadia, MD¹, Alessandra Ferrajoli, MD¹, Yesid Alvarado, MD¹, Gautam Borthakur, MD¹, Naveen Pemmaraju, MD¹, Marina Konopleva, MD, PhD², Guillermo Garcia-Manero, MD¹ and Courtney DiNardo, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Jehad Almasri, M.D.^1*, Hassan B Alkhateeb, MD², Moussab Damlaj, MD², Zhen Wang, Ph.D.^1*, M. Hassan Murad, M.D.^1* and Aref Al-Kali, MD²

¹Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN

Francesco Arcioni, MD^1*, Andrea Roncadori^2*, Valeria Di Battista, MD^3*, Giuliana Alimena, MD⁴, Fabrizio Pane, MD⁵, Giuseppe Rossi⁶, Francesco Buccisano, MD,⁷, Anna D'Emilio, MD^8*, Nicola Di Renzo⁹, Pietro Leoni, Prof.¹⁰, Giovanni Caocci^11*, Alessandro Rambaldi, MD¹², Paolo Avanzini^13*, Giuseppe Visani, M.D.^14*, Sante Tura, MD^15*, Anna Covezzoli^16* and Cristina Mecucci, MD, PhD¹⁷

¹Pediatric Onco-Hematology, Ospedale Santa Maria della Misericordia, Perugia, Perugia, Italy
²Non profit Interuniversity Consortium, CINECA, Casalecchio Di Reno, Bologna, bologna, Italy
³Hematology Unit, University of Perugia, Perugia, Italy
⁴Department of Cellular Biotechnologies and Hematology, Hematology, Sapienza University, Rome, Italy
⁵A.F. di Oncologia Ematologica Diagnostica, Azienda Ospedaliera, Napoli, Italy
⁶Hematology, Spedali Civili di Brescia, Brescia, Italy
⁷Hematology, University Tor Vergata, Rome, Italy
⁸Hematology, San Bortolo Hospital, Vicenza, Italy
⁹Hematology, Vito Fazzi Hospital, Lecce, Italy
¹⁰Clinic of Hematology, Polytechnic University of Marche, Ospedali Riuniti, Ancona, Italy
¹¹Department of Medical Sciences, University of Cagliari, Cagliari, Italy
¹²Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
¹³Hematology, Ospedale Santa Maria Nuova, Reggio Emilia, Reggio Emilia, Italy
¹⁴Hematology, San Salvatore Hospital, Pesaro, Italy
¹⁵University of Bologna, Bologna, Italy
¹⁶Non profit Interuniversity Consortium, CINECA, Casalecchio Di Reno, Bologna, Casalecchio Di Reno, Bologna, Italy
¹⁷Hematology and Bone Marrow Transplantation Unit, University of Perugia, Perugia, Italy

Hae Tha Mya, MRCP, FRCPath^1,2*, Maria Diez Campelo, MD, PhD^1,3*, Sandra Valle Herrero, MD^4*, Agustin Díaz-Alvarez, MD, PhD^5*, Domingo Bustos, MD^5*, Luis M Vaquero, MD^5*, José J Pérez^1*, Verónica González, MD^1*, Jose M Bastida, MD^1*, Carlos Aguilar, MD^6*, Abelardo Bárez, MD^7*, Noemi Puig, MD, PhD^1,3*, Alejandro Martin-Sancho, MD, PhD^1,3*, María Jesús Garcia^1*, Irene Aires^1*, Sara Alonso, MD^1*, Marcos González, MD, PhD^3,8*, Consuelo Del Cañizo, MD, PhD^1,3 and Maria Belen Vidriales, MD, PhD^1,3*

¹Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
²Department of Hematology, Singapore General Hospital, Singapore, Singapore
³Instituto Biosanitario de Salamanca (IBSAL) and Cancer Research Centre (Instituto de Biología Molecular y Celular del Cáncer; CSIC-USAL), Salamanca, Spain
⁴Department of Hematology, Hospital Santos Reyes, Aranda de Duero, Spain
⁵Department of Anestesiolgy, Hospital Universitario de Salamanca, Salamanca, Spain
⁶Department of Hematology, Hospital de Soria, Soria, Spain
⁷Department of Hematology, Hospital Nuestra Señora de Sonsoles, Avila, Spain
⁸Hospital Clínico Universitario de Salamanca, Salamanca, Spain

Jean-Baptiste Fraison^1*, Arsène Mekinian^2*, Eric Grignano^3*, Jean-Emmanuel Kahn^4*, Jean-Benoît Arlet^5*, Olivier Decaux^6*, Denis Guillaume^7*, Anne-Laure Buchdahl^8*, Mohamed Omouri^9*, Gwenola Maigne^10*, Achille Aouba^10*, Nathalie Leon^11*, Sabine Berthier^12*, Eric Liozon^13*, Sophie Park^14*, Claude Gardin^15*, Olivier Lortholary^16*, Julien Rossignol^3*, Pierre Fenaux, MD, PhD¹⁷, Olivier Fain^2* and Thorsten Braun^15*

¹Internal Medicine, Jean Verdier Hospital-University Paris XIII, Bondy, France
²Internal Medicine, Saint Antoine Hospital-University Paris VI, Paris, France
³Hematology, IGR, Villejuif, France
⁴Internal Medicine, Foch Hospital, Suresnes, France
⁵Georges Pompidou Hospital-Paris V University, Paris, France
⁶Internal Medicine, Rennes University Hospital, Rennes, France
⁷Internal Medicine, Rochefort Hospital, Rochefort, France
⁸Internal Medicine, Douai Hospital, Douai, France
⁹Internal Medicine, Romilly Hospital, Romilly, France
¹⁰Internal Medicine, University Hospital Caen, Caen, France
¹¹Rheumatology, University Hospital Caen, Caen, France
¹²Internal Medicine, University Hospital Dijon, Dijon, France
¹³Internal Medicine, University Hospital Limoges, Limoges, France
¹⁴Hematology, University Hospital Grenoble, Grenoble, France
¹⁵Hematology Department, Avicenne Hospital, APHP, University Paris 13, Bobigny, France
¹⁶Infectious Diseases, Necker Hospital-University Paris V, Paris, France
¹⁷Service d’Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France

Mikkael A. Sekeres, MD, MS¹, Katrina Zell, MA, MS^1*, John Barnard, PhD^1*, Amy E. DeZern, MD, MHS², David P. Steensma, MD³, Cassie Zimmerman, MPH^1*, Christopher Estling, MS^1*, Wesley Hand^2*, Gail J. Roboz, MD⁴, Nicole Rizzo^4*, Najla H. Al Ali, BDS, MSc^5*, Alan F. List, MD⁵, Guillermo Garcia-Manero, MD⁶, Jaroslaw P. Maciejewski, MD, PhD¹ and Rami S. Komrokji, MD⁵

¹Leukemia Program, Cleveland Clinic, Cleveland, OH
²Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY
⁵Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁶Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Rami S. Komrokji, MD¹, Amy E. DeZern, MD, MHS², Katrina Zell, MA, MS^3*, Najla H. Al Ali, BDS, MSc^1*, Eric Padron, MD¹, Christopher Estling^3*, Cassie Zimmerman, MPH^3*, Wesley Hand^2*, Francis Brown^4*, Nicole Rizzo^5*, John Barnard, PhD^3*, Gail J Roboz, MD⁶, Hetty E. Carraway, MD, MBA³, Jaroslaw P. Maciejewski, MD, PhD³, Alan F. List, MD¹, Guillermo Garcia-Manero, MD⁷, David P. Steensma, MD⁴ and Mikkael A. Sekeres, MD, MS³

¹Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
³Leukemia Program, Cleveland Clinic, Cleveland, OH
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY
⁶Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College, New York, NY
⁷Department of Leukemia, MD Anderson Cancer Center, Houston, TX

Ateefa Chaudhury, MD^1,2, Rami S. Komrokji, MD^1,3, Najla H. Al Ali, BDS, MSc^1*, Ling Zhang, MD⁴, Pardis Vafaii, MD^4* and Jeffrey E. Lancet, MD¹

¹Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²Department of Internal Medicine, Division of Hematology and Medical Oncology, University of South Florida, Tampa, FL
³Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁴Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Aleksandar Radujkovic, MD^1*, Paul Schnitzler, MD^2*, Anthony D. Ho, MD³, Peter Dreger, MD¹ and Thomas Luft, MD, PhD¹

¹Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
²Department of Infectious Diseases, Virology, University of Heidelberg, Heidelberg, Germany
³Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany

Masayuki Shiseki, MD, PhD¹, Mayuko Ishii^1*, Mari Ohwashi^2*, Kentaro Yoshinaga, MD, PhD^1*, Naoki Mori, MD, PhD^1* and Junji Tanaka, M.D., Ph.D.¹

¹Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan
²Tokyo Women's Medical University, Tokyo, Japan

Ambica Parmar, MD^1*, Heather A Leitch, MD, PhD², Richard A. Wells, MD, DPhil³, Thomas J. Nevill, MD, FRCPC⁴, Nancy Y Zhu, MD FRCPC^5*, Karen W.L. Yee, MD⁶, Brian Leber, MD⁷, Mitchell Sabloff, MDCM⁸, Eve St-Hilaire, MD^9*, Rajat Kumar, MD¹⁰, Michelle Geddes, MD, FRCPC¹¹, John Storring, MD¹², Andrea Kew, MD¹³, April Shamy, MDCM¹⁴, Mohamed Elemary, MD, MSc, PhD.¹⁵, Martha Lenis^16*, Alex Mamedov^16* and Rena Buckstein, MD, FRCPC¹⁷

¹University of Toronto, Toronto, ON, Canada
²Hematology, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada
³Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
⁴Leukemia/BMT Program of British Columbia, Division of Hematology, Vancouver, BC, Canada
⁵Hematology/Oncology, University of Alberta 8440 - 112 Street, Edmonton, AB, Canada
⁶Princess Margaret Hospital, Toronto, ON, Canada
⁷McMaster University, Hamilton, ON, Canada
⁸Ottawa General Hospital, Ottawa, ON, Canada
⁹Centre d'oncologie Dr-Leon-Richard,, Moncton, NB, Canada
¹⁰Hematology/Oncology, CancerCare Manitoba, Winnipeg, MB, Canada
¹¹Department of Medicine/Hematology, Foothills Medical Centre, Calgary, AB, Canada
¹²McGill Montreal General Hospital, Montreal, QC, Canada
¹³Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
¹⁴Sir Mortimer B. Davis Hospital, McGill University, Montreal, QC, Canada
¹⁵Saskatoon Cancer Center, University of Saskatchewan, Saskatoon, SK, Canada
¹⁶Odette Cancer Center, Sunnybrook Health Sciences Center, Toronto, ON, Canada
¹⁷Sunnybrook Health Sciences Centre, Odette Cancer Centre, Toronto, ON, Canada

Ramesh Babu, Ph.D., MBA^1* and Nagesh Rao, Ph.D.^2*

¹InteGen LLC, Orlando, FL
²David Geffen UCLA School of Medicine, Los Angeles, CA

Kankana Ghosh, B. Pharm^1*, Parsa Hodjat, MD^2*, Priyanka Priyanka, MPH^3*, Beenu Thakral, MBBS, MD^2*, Keyur P. Patel, MD, PhD^2*, Mark Routbort, MD, PhD^2*, Rashmi Kanagal-Shamana, MD^2*, C. Cameron Yin, MD, PhD², Zhuang Zuo, MD, PhD^2*, Raja Luthra, PhD^2* and Tariq Muzzafar, MD²

¹The University of Texas, School of Public Health, Houston, TX
²Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX

Francesca Schieppati^1*, Erin P. Demakos, RN, CCRN^2*, Odchimar Rosalie-Reissig, RN^3*, Shyamala C. Navada, MD⁴ and Lewis R. Silverman, MD⁴

¹Division of Hematology, A.O. Spedali Civili of Brescia, Brescia, Italy
²Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY
³Tisch Cancer Institute, Icahn School of Medicine, New York, NY
⁴Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

David Sallman, M.D.¹, Guillermo Garcia-Manero, MD², Elias Jabbour³, Mikkael A. Sekeres, MD, MS⁴, Amy E. DeZern, MD, MHS⁵, David P. Steensma, MD⁶, Gail J. Roboz, MD⁷, John Barnard, PhD^4*, Najla H. Al Ali, BDS, MSc^8*, Cassie Zimmerman, MPH^4*, Sherry Pierce, BSN, BA^9*, Denise Batista, PhD^10*, Jeffrey E Lancet, MD⁸, Eric Padron, M.D.¹¹, Jaroslaw P. Maciejewski, MD, Ph.D.¹², Alan F. List, MD¹³, Hagop M. Kantarjian, MD⁹ and Rami S. Komrokji, MD⁸

¹Dept. of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
²Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
³The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Leukemia Program, Cleveland Clinic, Cleveland, OH
⁵Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁷Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY
⁸Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Johns Hopkins School of Medicine, Baltimore, MD
¹¹Division of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL
¹²Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹³Department of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL